We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Avidity Biosciences Inc | NASDAQ:RNA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 24.70 | 23.25 | 26.20 | 2 | 09:39:46 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
||
SCHEDULE 13G
|
||
Under the Securities Exchange Act of 1934
|
||
(Amendment No. __)*
|
||
Avidity Biosciences, Inc.
|
||
(Name of Issuer)
|
||
Common Stock
|
||
(Title of Class of Securities)
|
05370A108
|
||
(CUSIP Number)
|
December 14, 2022
|
||
(Date of Event which Requires Filing of this Statement)
|
[ ] |
Rule 13d-1(b)
|
[x] |
Rule 13d-1(c)
|
[ ] |
Rule 13d-1(d)
|
CUSIP NO.
|
05370A108
|
1
|
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only)
Cormorant Global Healthcare Master Fund, LP
|
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
(a) [ ]
|
||
(b) [x]
|
||
3
|
SEC Use Only
|
|
4
|
Citizenship or Place of Organization.
Cayman Islands
|
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole Voting Power
0 shares
|
|
6 Shared Voting Power
1,000,000 shares as of December 14, 2022
Refer to Item 4 below.
|
||
7 Sole Dispositive Power
0 shares
|
||
8 Shared Dispositive
Power
1,000,000 shares as of December 14, 2022
Refer to Item 4 below.
|
||
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
1,000,000 shares as of December 14, 2022
Refer to Item 4 below.
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
[ ] N/A
|
|
11
|
Percent of Class Represented by Amount in Row (9)*
1.84% as of December 14, 2022 (1.50% as of the date of filing)
Refer to Item 4 below.
|
|
12
|
Type of Reporting Person (See Instructions)
PN (Partnership)
|
CUSIP NO.
|
05370A108
|
1
|
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only)
Cormorant Global Healthcare GP, LLC
|
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
(a) [ ]
|
||
(b) [x]
|
||
3
|
SEC Use Only
|
|
4
|
Citizenship or Place of Organization.
Delaware
|
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole Voting Power
0 shares
|
|
6 Shared Voting Power
1,000,000 shares as of December 14, 2022
Refer to Item 4 below.
|
||
7 Sole Dispositive Power
0 shares
|
||
8 Shared Dispositive
Power
1,000,000 shares as of December 14, 2022
Refer to Item 4 below.
|
||
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
1,000,000 shares as of December 14, 2022
Refer to Item 4 below.
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
[ ] N/A
|
|
11
|
Percent of Class Represented by Amount in Row (9)*
1.84% as of December 14, 2022 (1.50% as of the date of filing)
Refer to Item 4 below.
|
|
12
|
Type of Reporting Person (See Instructions)
OO (Limited Liability Company)
|
CUSIP NO.
|
05370A108
|
1
|
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only)
Cormorant Private Healthcare Fund II, LP
|
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
(a) [ ]
|
||
(b) [x]
|
||
3
|
SEC Use Only
|
|
4
|
Citizenship or Place of Organization.
Delaware
|
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole Voting Power
0 shares
|
|
6 Shared Voting Power
1,762,115 shares as of December 14, 2022
Refer to Item 4 below.
|
||
7 Sole Dispositive Power
0 shares
|
||
8 Shared Dispositive
Power
1,762,115 shares as of December 14, 2022
Refer to Item 4 below.
|
||
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
1,762,115 shares as of December 14, 2022
Refer to Item 4 below.
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
[ ] N/A
|
|
11
|
Percent of Class Represented by Amount in Row (9)*
3.24% as of December 14, 2022 (2.65% as of the date of filing)
Refer to Item 4 below.
|
|
12
|
Type of Reporting Person (See Instructions)
PN (Partnership)
|
CUSIP NO.
|
05370A108
|
1
|
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only)
Cormorant Private Healthcare GP II, LLC
|
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
(a) [ ]
|
||
(b) [x]
|
||
3
|
SEC Use Only
|
|
4
|
Citizenship or Place of Organization.
Delaware
|
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole Voting Power
0 shares
|
|
6 Shared Voting Power
1,762,115 shares as of December 14, 2022
Refer to Item 4 below.
|
||
7 Sole Dispositive Power
0 shares
|
||
8 Shared Dispositive
Power
1,762,115 shares as of December 14, 2022
Refer to Item 4 below.
|
||
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
1,762,115 shares as of December 14, 2022
Refer to Item 4 below.
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
[ ] N/A
|
|
11
|
Percent of Class Represented by Amount in Row (9)*
3.24% as of December 14, 2022 (2.65% as of the date of filing)
Refer to Item 4 below.
|
|
12
|
Type of Reporting Person (See Instructions)
OO (Limited Liability Company)
|
CUSIP NO.
|
05370A108
|
1
|
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only)
Cormorant Asset Management, LP
|
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
(a) [ ]
|
||
(b) [x]
|
||
3
|
SEC Use Only
|
|
4
|
Citizenship or Place of Organization.
Delaware
|
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole Voting Power
0 shares
|
|
6 Shared Voting Power
2,762,115 shares as of December 14, 2022
Refer to Item 4 below.
|
||
7 Sole Dispositive Power
0 shares
|
||
8 Shared Dispositive
Power
2,762,115 shares as of December 14, 2022
Refer to Item 4 below.
|
||
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
2,762,115 shares as of December 14, 2022
Refer to Item 4 below.
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
[ ] N/A
|
|
11
|
Percent of Class Represented by Amount in Row (9)*
5.07% as of December 14, 2022 (4.16% as of the date of filing)
Refer to Item 4 below.
|
|
12
|
Type of Reporting Person (See Instructions)
PN (Partnership)
|
CUSIP NO.
|
05370A108
|
1
|
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only)
Bihua Chen
|
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
(a) [ ]
|
||
(b) [x]
|
||
3
|
SEC Use Only
|
|
4
|
Citizenship or Place of Organization.
United States
|
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole Voting Power
0 shares
|
|
6 Shared Voting Power
2,762,115 shares as of December 14, 2022
Refer to Item 4 below.
|
||
7 Sole Dispositive Power
0 shares
|
||
8 Shared Dispositive
Power
2,762,115 shares as of December 14, 2022
Refer to Item 4 below.
|
||
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
2,762,115 shares as of December 14, 2022
Refer to Item 4 below.
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
[ ] N/A
|
|
11
|
Percent of Class Represented by Amount in Row (9)*
5.07% as of December 14, 2022 (4.16% as of the date of filing)
Refer to Item 4 below.
|
|
12
|
Type of Reporting Person (See Instructions)
IN (Individual)
|
CUSIP NO.
|
05370A108
|
(a)
|
Name of Issuer
|
|
Avidity Biosciences, Inc.
|
||
(b)
|
Address of Issuer’s Principal Executive Offices
|
|
10578 Science Center Drive, Suite 125, San Diego, CA 92121
|
(a)
|
Name of Person Filing
|
|
Cormorant Global Healthcare Master Fund, LP
Cormorant Global Healthcare GP, LLC Cormorant Private Healthcare Fund II, LP Cormorant Private Healthcare GP II, LLC
Cormorant Asset Management, LP Bihua Chen |
||
(b)
|
Address of Principal Business Office or, if none, Residence
|
|
200 Clarendon Street, 52nd Floor
Boston, MA 02116
|
||
(c)
|
Citizenship
|
|
Cormorant Global Healthcare Master Fund, LP - Cayman Islands
Cormorant Global Healthcare GP, LLC - Delaware Cormorant Private Healthcare Fund II, LP - Delaware Cormorant Private Healthcare GP II, LLC - Delaware Cormorant Asset Management, LP - Delaware Bihua Chen - United States |
||
(d)
|
Title of Class of Securities
|
|
Common Stock
|
||
(e)
|
CUSIP Number
|
|
05370A108
|
CUSIP NO.
|
05370A108
|
Item 3. |
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
|
(a)
|
[ ]
|
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
|
|
(b)
|
[ ]
|
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
|
|
(c)
|
[ ]
|
Insurance Company as defined in Section 3(a)(19) of the Act
|
|
(d)
|
[ ]
|
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
|
|
(e)
|
[ ]
|
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
|
|
(f)
|
[ ]
|
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
|
|
(g)
|
[ ]
|
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
|
|
(h)
|
[ ]
|
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
|
(i)
|
[ ]
|
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
|
|
(j)
|
[ ]
|
A non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J);
|
|
(k)
|
[ ]
|
Group, in accordance with §240.13d-1(b)(1)(ii)(K).
|
Item 4. |
Ownership***
|
(a)
|
Amount Beneficially Owned***
|
||
The information set forth in Row 9 on the cover page for each Reporting Person is hereby incorporated by reference into this Item 4(a) for each such Reporting Person.
|
|||
(b)
|
Percent of Class***
|
||
The information set forth in Row 11 on the cover page for each Reporting Person is hereby incorporated by reference into this Item 4(b) for each such Reporting Person.
|
|||
(c)
|
Number of shares as to which such person has: ***
|
||
(i)
|
sole power to vote or to direct the vote
|
||
(ii)
|
shared power to vote or to direct the vote
|
||
(iii)
|
sole power to dispose or to direct the disposition of
|
||
(iv)
|
shared power to dispose or to direct the disposition of
|
||
CUSIP NO.
|
05370A108
|
Item 5. |
Ownership of Five Percent or Less of a Class
|
Item 6. |
Ownership of More than Five Percent on Behalf of Another Person
Not applicable. |
Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
Not applicable. |
Item 8. |
Identification and Classification of Members of the Group
Not applicable. |
Item 9. |
Notice of Dissolution of Group
Not applicable. |
Item 10. |
Certification
|
CUSIP NO.
|
05370A108
|
Exhibits |
Exhibit
|
99.1 |
Joint Filing Agreement by and among the Reporting Persons.
|
CUSIP NO.
|
05370A108
|
CORMORANT GLOBAL HEALTHCARE
|
||
MASTER FUND, LP
|
||
By:
|
Cormorant Global Healthcare GP, LLC
|
|
its General Partner
|
||
By: /s/ Bihua Chen
|
||
Bihua Chen, Managing Member
|
||
CORMORANT GLOBAL HEALTHCARE GP,
|
||
LLC
|
||
By: /s/ Bihua Chen
|
||
Bihua Chen, Managing Member
|
||
CORMORANT PRIVATE HEALTHCARE
|
||
FUND II, LP
|
||
By:
|
Cormorant Private Healthcare GP II, LLC
|
|
its General Partner
|
||
By: /s/ Bihua Chen
|
||
Bihua Chen, Managing Member
|
||
CORMORANT PRIVATE HEALTHCARE GP
|
||
II, LLC
|
||
By: /s/ Bihua Chen
|
||
Bihua Chen, Managing Member
|
||
CORMORANT ASSET MANAGEMENT, LP
|
||
By:
|
Cormorant Asset Management GP, LLC
|
|
its General Partner
|
||
By: /s/ Bihua Chen
|
||
Bihua Chen, Managing Member
|
||
/s/ Bihua Chen
|
||
Bihua Chen
|
1 Year Avidity Biosciences Chart |
1 Month Avidity Biosciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions